(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors ...

In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...

Living with Type 1 diabetes is a numbers game. There’s not a moment in the day free from the burden of tracking your blood ...

SAN DIEGO, January 30, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday ...

After hours: January 31 at 7:12:31 PM EST ...

TomoCredit, the financial wellness platform that helps immigrants and underserved groups get access to essential credit, released today these practical tips on how to use the latest AI technology to ...

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 60,000 newsletter subscribers for 21 days.